Also, blocking CXCL10/TLR4/MMP14 signaling to inhibit MDSCs mobilization and tumor cells invasion and metastasis will present a great potential for developing novel treatment strategies against HCC malignant progression and recurrence. This evidence concerns the gene MMP14 and hepatocellular carcinoma.